The global biopharmaceutical industry has witnessed steady growth over the years due to a surge in the sales of vaccines, statins, and therapeutics. This has, in turn, created a need for purification, thus increasing the demand for prepacked chromatography columns.
Prepacked chromatography columns have also been integrated in the biopharmaceutical industry and its acceptance is growing at a rapid pace. Government organizations in countries such as Canada, the U.S., and Germany have been upping their investments, grants, and funds in order to develop as well as bring innovative products to the market. This has also supported the prepacked chromatography columns market.
The global market is anticipated to expand at a CAGR of 8.4% during the forecast period, rising from a value of US$1.6 bn in 2015 to US$3.3 bn by 2024.
Based on product type, the >1L segment accounted for a share of just under 50% in the global prepacked chromatography columns market. The segment is expected to expand at a significant growth rate from 2016 to 2024. These columns can be used for clinical, preclinical, and small-scale and commercial large-scale manufacturing. The size of the >1L column market is likely to increase over the course of the forecast period due to a rise in the viability of larger-sized column production and a decrease in the cost of resins.
Major end users of prepacked chromatography columns include pharmaceutical biotechnology, the food and beverages, water and environmental, and nutraceutical industries, academics, research institutes, and analytical laboratories. The pharmaceutical biotechnology segment held a major share in the global prepacked chromatography columns market in 2015. The segment is driven by the high demand for purification on a commercial scale for the manufacture of biologics such as vaccines and monoclonal antibodies. Prepacked chromatography columns are widely used in the agriculture and food industries for the determination of pesticides and other additives in foods.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6014
North America accounted for a major share of 33.9% in the global prepacked chromatography columns market in 2015. Prepacked chromatography columns are rapidly developing analytical methods in North America due to increasing direct and indirect investments by the U.S. Government and private companies in chromatography. Increasing investments are likely to result in the development of new technologies, which will attract more customers, thereby driving the market. Extensive research and development activities in the U.S. also necessitate the high utilization of chromatography techniques.
Asia Pacific also held a prominent share in the global prepacked chromatography columns market and is anticipated to grow at a significant CAGR during the forecast period. The increasing usage of chromatographic techniques in disease diagnosis, the growing need for separation process in small laboratories, quality control in the industry, and the rising demand for the commercial production of biologics have driven the Asia Pacific market over the years.
Brazil is one of the most attractive and favorable pharmaceutical markets in the world and as a result, the prepacked chromatography column market in Latin America holds immense promise.
Agilent Technologies, Inc., Biorad Laboratories Inc., Danaher Corporation, EMD Millipore (Merck KGaA), GE Healthcare, KNAUER Wissenschaftliche Geräte GmbH, Repligen Corporation, and Thermo Fisher Scientific, Inc. are some of the key players contributing to the growth of the global prepacked chromatography columns market.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453